HeartCore Enterprises, Inc. announced that its client SBC Medical Group Holdings Inc. has started trading on Nasdaq, generating $17.9 million in revenue from the deal, with $17 million to be recognized in Q3 2024. The company holds $8 million in SBC stock and projects Q3 revenue between $19 million and $23 million, with net profit expected between $4 million and $8 million.